Matthias Bieg

Matthias Bieg

Auto-generated profile, based on publicly available information

Matthias Bieg

Center for Digital Health, Berlin Institute of Health and Charité-Universitätsmedizin Berlin, Berlin, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in The American Journal of Pathology
Verified
Journal Article
Closed access
MBMatthias Bieg
Matthias Bieg
EMEvgeny Moskalev
Evgeny Moskalev
RWRainer Will
Rainer Will
SHSimone Hebele
Simone Hebele
MSMatthias Schwarzbach
Matthias Schwarzbach
FHFlorian Haller
Florian Haller

15 July 2020 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
BFBohai Feng
Bohai Feng
YSYing Shen
Ying Shen
XHXavier Pastor Hostench
Xavier Pastor Hostench
MBMatthias Bieg
Matthias Bieg
MPMichaela Plath
Michaela Plath
JHJochen Hess
Jochen Hess
Purpose: Malignant progression exhibits a tightly orchestrated balance between immune effector response and tolerance. However, underlying molecular principles that drive the establishment and maintenance of the tumor immune phenotype remain to be elucidated.Experimental Design: We trained a novel molecular classifier based on immune cell subsets related to programmed death-ligand 1 (PD-L1) and interferon γ (IFNγ) expression, which revealed distinct subgroups with higher (cluster A) or lower (subcluster B3) cytotoxic immune phenotypes. Integrative analysis of multi-omics data was conducted to identify differences in genetic and epigenetic landscapes as well as their impact on differentially expressed genes (DEG) among immune phenotypes. A prognostic gene signature for immune checkpoint inhibition (ICI) was established by a least absolute shrinkage and selection operator (LASSO)-Cox regression model.Results: Mutational landscape analyses unraveled a higher frequency of CASP8 somatic mutations in subcluster A1, while subcluster B3 exhibited a characteristic pattern of copy-number alterations affecting chemokine signaling and immune effector response. The integrative multi-omics approach identified EGFR and PTGS2 as key nodes in a gene regulatory network related to the immune phenotype, and several DEGs related to the immune phenotypes were affected by EGFR inhibition in tumor cell lines. Finally, we established a prognostic gene signature by a LASSO-Cox regression model based on DEGs between nonprogressive disease and progressive disease subgroups for ICI.Conclusions: Our data highlight a complex interplay between genetic and epigenetic events in the establishment of the tumor immune phenotype and provide compelling experimental evidence that a patient with squamous cell carcinoma of the head and neck at higher risk for ICI treatment failure might benefit from a combination with EGFR inhibition.

10 February 2023 in Allergy
Verified
Journal Article
Open access
LTLoreen Thürmann
Loreen Thürmann
MKMatthias Klös
Matthias Klös
SMSebastian D. Mackowiak
Sebastian D. Mackowiak
MBMatthias Bieg
Matthias Bieg
TBTobias Bauer
Tobias Bauer
ILIrina Lehmann
Irina Lehmann
Background: Childhood asthma is a result of a complex interaction of genetic and environmental components causing epigenetic and immune dysregulation, airway inflammation and impaired lung function. Although different microarray based EWAS studies have been conducted, the impact of epigenetic regulation in asthma development is still widely unknown. We have therefore applied unbiased whole genome bisulfite sequencing (WGBS) to characterize global DNA‐methylation profiles of asthmatic children compared to healthy controls. Methods: Peripheral blood samples of 40 asthmatic and 42 control children aged 5–15 years from three birth cohorts were sequenced together with paired cord blood samples. Identified differentially methylated regions (DMRs) were categorized in genotype‐associated, cell‐type‐dependent, or prenatally primed. Network analysis and subsequent natural language processing of DMR‐associated genes was complemented by targeted analysis of functional translation of epigenetic regulation on the transcriptional and protein level. Results: In total, 158 DMRs were identified in asthmatic children compared to controls of which 37% were related to the eosinophil content. A global hypomethylation was identified affecting predominantly enhancer regions and regulating key immune genes such as IL4 , IL5RA , and EPX . These DMRs were confirmed in n = 267 samples and could be linked to aberrant gene expression. Out of the 158 DMRs identified in the established phenotype, 56 were perturbed already at birth and linked, at least in part, to prenatal influences such as tobacco smoke exposure or phthalate exposure. Conclusion: This is the first epigenetic study based on whole genome sequencing to identify marked dysregulation of enhancer regions as a hallmark of childhood asthma.

1 July 2021 in The American Journal of Pathology
Verified
Journal Article
Closed access
FHFlorian Haller
Florian Haller
LSLea D Schlieben
Lea D Schlieben
FFFulvia Ferrazzi
Fulvia Ferrazzi
MMMichael Michal
Michael Michal
RSRobert Stöhr
Robert Stöhr
AAAbbas Agaimy
Abbas Agaimy

17 February 2021 in Epigenetics
Verified
Journal Article
Open access
MLMarina Laplana
Marina Laplana
MBMatthias Bieg
Matthias Bieg
CFChristian Faltus
Christian Faltus
SMSvitlana Melnik
Svitlana Melnik
OBOlga Bogatyrova
Olga Bogatyrova
ARAngela Risch
Angela Risch
Genome-wide association studies (GWAS) have identified SNPs linked with lung cancer risk. Our aim was to discover the genes, non-coding RNAs, and regulatory elements within GWAS-identified risk regions that are deregulated in non-small cell lung carcinoma (NSCLC) to identify novel, clinically targetable genes and mechanisms in carcinogenesis. A targeted bisulphite-sequencing approach was used to comprehensively investigate DNA methylation changes occurring within lung cancer risk regions in 17 NSCLC and adjacent normal tissue pairs. We report differences in differentially methylated regions between adenocarcinoma and squamous cell carcinoma. Among the minimal regions found to be differentially methylated in at least 50% of the patients, 7 candidates were replicated in 2 independent cohorts (n = 27 and n = 87) and the potential of 6 as methylation-dependent regulatory elements was confirmed by functional assays. This study contributes to understanding the pathways implicated in lung cancer initiation and progression, and provides new potential targets for cancer treatment.

1 January 2020 in Biology Open
Verified
Journal Article
Open access
PDF file
EAEnoch Boasiako Antwi
Enoch Boasiako Antwi
AOAda Olins
Ada Olins
VTVladimir Teif
Vladimir Teif
MBMatthias Bieg
Matthias Bieg
TBTobias Bauer
Tobias Bauer
Naveed IshaqueNaveed Ishaque
Naveed Ishaque
Epigenomic regulation plays a vital role in cell differentiation. The leukemic HL-60/S4 [human myeloid leukemic cell line HL-60/S4 (ATCC CRL-3306)] promyelocytic cell can be easily differentiated from its undifferentiated promyelocyte state into neutrophil- and macrophage-like cell states. In this study, we present the underlying genome and epigenome architecture of HL-60/S4 through its differentiation. We performed whole-genome bisulphite sequencing of HL-60/S4 cells and their differentiated counterparts. With the support of karyotyping, we show that HL-60/S4 maintains a stable genome throughout differentiation. Analysis of differential Cytosine-phosphate-Guanine dinucleotide methylation reveals that most methylation changes occur in the macrophage-like state. Differential methylation of promoters was associated with immune-related terms. Key immune genes, CEBPA, GFI1, MAFB and GATA1 showed differential expression and methylation. However, we observed the strongest enrichment of methylation changes in enhancers and CTCF binding sites, implying that methylation plays a major role in large-scale transcriptional reprogramming and chromatin reorganisation during differentiation. Correlation of differential expression and distal methylation with support from chromatin capture experiments allowed us to identify putative proximal and long-range enhancers for a number of immune cell differentiation genes, including CEBPA and CCNF. Integrating expression data, we present a model of HL-60/S4 differentiation in relation to the wider scope of myeloid differentiation.